The effect of high intensity statin use on liver density: A post hoc analysis of the coronary artery calcification treatment with zocor [CATZ] study

Obes Res Clin Pract. 2016 Sep-Oct;10(5):613-615. doi: 10.1016/j.orcp.2016.09.001. Epub 2016 Sep 23.

Authors

Sudipa Sarkar¹, James G Terry², T Alp Ikizler³, John R Crouse 3rd⁴, J Jeffrey Carr², Adriana M Hung⁵

Affiliations

¹ Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: sudipa.sarkar@vanderbilt.edu.
² Department of Radiology and Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University, Nashville, TN, USA.
³ Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA.
⁴ Department of Medicine, Wake Forest University, Winston-Salem, NC, USA.
⁵ Veterans Administration Tennessee Valley Healthcare System and Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA.

PMID: 27670349
DOI: 10.1016/j.orcp.2016.09.001

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Coronary Artery Disease / diagnostic imaging
Coronary Artery Disease / drug therapy*
Coronary Artery Disease / physiopathology
Disease Progression
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Liver / diagnostic imaging*
Liver / pathology
Male
Middle Aged
Non-alcoholic Fatty Liver Disease / diagnostic imaging
Non-alcoholic Fatty Liver Disease / drug therapy*
Non-alcoholic Fatty Liver Disease / physiopathology
Plaque, Atherosclerotic / diagnostic imaging
Plaque, Atherosclerotic / drug therapy*
Radiography, Abdominal
Simvastatin / pharmacology*
Simvastatin / therapeutic use
Tomography, X-Ray Computed
Treatment Outcome
Young Adult

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin

Grants and funding